Anti-SIRP alpha/CD172a antibody

Anti-SIRP alpha/CD172a antibody

• DataSheet
• Material Safety Data Sheets (MSDS)

Rabbit monoclonal to SIRP alpha/CD172a

FCM

Mouse SIRP alpha / CD172a

p84 antibody; AI835480 antibody; Bit antibody; BIT antibody; CD172a antibody; CD172A antibody; MFR antibody; MYD-1 antibody; P84 antibody; P84 antibody; Ptpns1 antibody; PTPNS1 antibody; RP23-37B4.2 antibody; SHP-1 antibody; SHPS1 antibody; SHPS-1 antibody; SIRP antibody; SIRP antibody; SIRP alpha antibody; SIRP alpha antibody; SHP-1 antibody; Bit antibody; SIRP antibody; CD172a antibody; Ptpns1 antibody; SHPS-1 antibody; AI835480 antibody; BIT antibody; MFR antibody; P84 antibody; SIRP antibody; MYD-1 antibody; SHPS1 antibody; CD172A antibody; PTPNS1 antibody

Rabbit IgG

This antibody was obtained from a rabbit immunized with purified, recombinant Mouse SIRP alpha / CD172a (rM SIRP alpha / CD172a; BAA20376.1; Met1-Asn373) and conjugated with PE under optimum conditions, the unreacted PE was removed.

Monoclonal

Aqueous solution containing 0.5% BSA and 0.09% sodium azide

This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

FCM

Tyrosine-protein phosphatase non-receptor type substrate 1, also known as SHP substrate 1, Inhibitory receptor SHPS-1, Brain Ig-like molecule with tyrosine-based activation motifs, Macrophage fusion receptor, CD172 antigen-like family member A, SIRPA and CD172a, is a single-pass type I membrane protein which contains two Ig-like C1-type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. SIRPA is ubiquitously expressed. It is highly expressed in brain and detected at lower levels in heart, placenta, lung, testis, ovary, colon, liver, small intestine, prostate, spleen, kidney, skeletal muscle and pancreas. It is also detected on myeloid cells, but not T-cells. SIRPA is an immunoglobulin-like cell surface receptor for CD47. SIRPA acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. SIRPA supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. It may play a key role in intracellular signaling during synaptogenesis and in synaptic function. SIRPA is involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin. It mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation.

• Timms JF. et al., 1999, Curr Biol. 9: 927-30.
• Stofega MR. et al., 2000, J Biol Chem. 275: 28222-9.
• Liu T. et al., 2005, J Proteome Res. 4: 2070-80.
• Wolf-Yadlin A. et al., 2007, Proc Natl Acad Sci. 104: 5860-5.